TriMas Corp. (TRS) Misses Q4 EPS by 16c ; Offers Guidance
Tweet
Share
E-mailGet Alerts TRS Hot Sheet
Price: $38.70 -1.38%
Financial Fact:
Net income per share: 0.19
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net income per share: 0.19
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
TriMas Corp. (NASDAQ: TRS) reported Q4 EPS of $0.37, $0.16 worse than the analyst estimate of $0.53. Revenue for the quarter came in at $209.6 million versus the consensus estimate of $246.44 million.
GUIDANCE:
TriMas Corp. sees FY2024 EPS of $1.95-$2.15, versus the consensus of $2.32.
For earnings history and earnings-related data on TriMas Corp. (TRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
